The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

Blood Check After Surgical procedure Might Predict Colon Most cancers Recurrence Danger

For folks recognized with stage 3 colon most cancers, one of the urgent questions after surgical procedure is whether or not the...

Knowledgeable Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma

Dr. Myron Czuczman highlighted the importance of the current U.S. Meals and Drug Administration (FDA) approval of Lymphir (denileukin diftitox-cxdl) for sufferers...

Physician Outlines Cervical Most cancers Care, Aspect Results, HPV Prevention

Throughout Cervical Most cancers Consciousness Month, Dr. Merieme Klobocista, a gynecologic surgical oncologist affiliated with Hackensack College Medical Heart and the John...

Why Medical Trials Could Supply Extra for Sufferers With GI Cancers

Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medication on the Cleveland Clinic...

Breaking Down Surgical Developments for These With Breast Most cancers

CURE just lately sat down for an interview with Dr. Kathie-Ann Joseph to debate surgical developments that these with breast most cancers...

Hot Topics